Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluation the efficacy and safety of autologous fecal bacteria transplantation in preventing acute graft versus host disease after haploidentical hematopoietic stem cell transplantation. Bone marrow transplant patients were recruited.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| with auto-FMT | Experimental | The patients in the experimental group took autologous fecal bacteria capsule about 3 weeks after bone marrow transplantation. |
|
| empty capsule | No Intervention | The patients in this group took empty capsule about 3 weeks after bone marrow transplantation |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| autologous fecal bacteria | Other | autologous fecal bacteria transplantation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Acute Graft-Versus-Host Disease | 90 days after haploidentical hematopoietic stem cell transplantation |
| Measure | Description | Time Frame |
|---|---|---|
| overall survival | 90 days after haploidentical hematopoietic stem cell transplantation | |
| Event free survival | 90 days after haploidentical hematopoietic stem cell transplantation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ye Zhao | Recruiting | Suzhou | Jiangsu | 215006 | China |
Not provided
| ID | Term |
|---|---|
| D006086 | Graft vs Host Disease |
| ID | Term |
|---|---|
| D007154 | Immune System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided